GRP
BCAX

Global Retirement Partners’s Bicara Therapeutics BCAX Stock Holding History

Global Retirement Partners’s Portfolio BCAX Stock Details BCAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.25K Buy
+143
New +$3.19K ﹤0.01% 3747
2025
Q4 		$1.99K Buy
118
+13
+12% +$222 ﹤0.01% 3735
2025
Q3 		$1.66K Buy
+105
New +$1.18K ﹤0.01% 3376

Other funds holding BCAX

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
RTM
Red Tree Management Redwood City, California $147M AUM 202.18% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Global Retirement Partners's BCAX Position: Q2 2026 in Review

Global Retirement Partners opened a new position in Bicara Therapeutics (BCAX) in Q2 2026: 143 shares worth $4.25K. The stake represents ﹤0.01% of the portfolio and ranks #3747 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in BCAX as recently as Q4 2025.

Global Retirement Partners first reported a position in BCAX in Q3 2025 and has held it in 3 quarters since. 172 funds tracked by Wall St. Rank hold BCAX as of Q2 2026.

  • Global Retirement Partners held 143 shares of Bicara Therapeutics worth $4.25K as of Q2 2026.
  • Bicara Therapeutics was a new Global Retirement Partners position in Q2 2026.
  • Bicara Therapeutics made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #3747 holding.
  • Global Retirement Partners first reported a position in Bicara Therapeutics in Q3 2025 and has held it in 3 quarters since.
  • 172 funds tracked by Wall St. Rank held Bicara Therapeutics as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.